Ectopic Pregnancy Risk in Users of Levonorgestrel-Releasing Intrauterine Systems With 52, 19.5, and 13.5 mg of Hormone.
作者信息
Meaidi Amani, Torp-Pedersen Christian, Lidegaard Øjvind, Mørch Lina Steinrud
机构信息
The Danish Cancer Society Research Center, Cancer Surveillance and Pharmacoepidemiology, Copenhagen, Denmark.
Department of Cardiology, North Zealand Hospital, Hilleroed, Denmark.
出版信息
JAMA. 2023 Mar 21;329(11):935-937. doi: 10.1001/jama.2023.0380.
Abstract
摘要
相似文献
1
Ectopic Pregnancy Risk in Users of Levonorgestrel-Releasing Intrauterine Systems With 52, 19.5, and 13.5 mg of Hormone.
JAMA. 2023 Mar 21;329(11):935-937. doi: 10.1001/jama.2023.0380.
2
Heterotopic cesarean scar pregnancy associated with a levonorgestrel-releasing intrauterine device.
Int J Gynaecol Obstet. 2011 Aug;114(2):153-4. doi: 10.1016/j.ijgo.2011.02.021. Epub 2011 Jun 15.
3
Ectopic Pregnancy Risk and Levonorgestrel-Releasing Intrauterine Systems.
JAMA. 2023 Jul 25;330(4):378. doi: 10.1001/jama.2023.8888.
4
Ectopic Pregnancy Risk and Levonorgestrel-Releasing Intrauterine Systems-Reply.
JAMA. 2023 Jul 25;330(4):378-379. doi: 10.1001/jama.2023.8891.
5
Levonorgestrel intrauterine contraceptive systems (13.5 mg and 52 mg) and risk of ectopic pregnancy.
Acta Obstet Gynecol Scand. 2019 Jul;98(7):937-943. doi: 10.1111/aogs.13564. Epub 2019 Mar 14.
6
The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device.
Arterioscler Thromb Vasc Biol. 2010 Nov;30(11):2297-300. doi: 10.1161/ATVBAHA.110.211482. Epub 2010 Aug 26.
7
Levonorgestrel-releasing (20 microgram/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives.
BJOG. 2000 Oct;107(10):1218-25. doi: 10.1111/j.1471-0528.2000.tb11610.x.
8
IUDs and ectopic pregnancy.
Contraception. 1995 Nov;52(5):321-2.
9
Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
Contraception. 1995 Nov;52(5):269-76. doi: 10.1016/0010-7824(95)00210-2.
10
Cohort Study of Psychiatric Adverse Events Following Exposure to Levonorgestrel-Containing Intrauterine Devices in UK General Practice.
Drug Saf. 2018 Oct;41(10):951-958. doi: 10.1007/s40264-018-0683-x.
引用本文的文献
1
Depression risk in users of different doses of levonorgestrel intrauterine systems: a nationwide prospective cohort study.
Lancet Reg Health Eur. 2024 Jan 5;38:100813. doi: 10.1016/j.lanepe.2023.100813. eCollection 2024 Mar.
本文引用的文献
1
The 13.5-mg, 19.5-mg, and 52-mg Levonorgestrel-Releasing Intrauterine Systems and Risk of Ectopic Pregnancy.
Obstet Gynecol. 2022 Aug 1;140(2):227-233. doi: 10.1097/AOG.0000000000004846. Epub 2022 Jul 6.
2
Method of Hormonal Contraception and Protective Effects Against Ectopic Pregnancy.
Obstet Gynecol. 2022 May 1;139(5):764-770. doi: 10.1097/AOG.0000000000004726. Epub 2022 Apr 5.
3
Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial.
Obstet Gynecol. 2013 Dec;122(6):1205-13. doi: 10.1097/AOG.0000000000000019.
4
A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena.
Fertil Steril. 2012 Mar;97(3):616-22.e1-3. doi: 10.1016/j.fertnstert.2011.12.003. Epub 2012 Jan 4.
Zotero 插件